Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Patent
1995-06-02
1998-08-04
Walsh, Stephen
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
530350, 5303881, G01N 3353, C07K 1444, C07K 1620
Patent
active
057891788
ABSTRACT:
Compositions enriched for Neutrophil Inhibitory Factor which inhibit neutrophil activity including adhesion to vascular endothelial cells are provided. Also provided are recombinant Neutrophil Inhibitory Factors which also which inhibit neutrophil activity. Such compositions may comprise a glycoprotein isolated from nematodes. These compositions and recombinant Neutrophil Inhibitory Factors are useful in the therapy of conditions which involve abnormal or undesired inflammatory responses.
REFERENCES:
patent: 4410633 (1983-10-01), Hartl et al.
patent: 4806467 (1989-02-01), Porter et al.
patent: 5391478 (1995-02-01), Greene et al.
patent: 5460945 (1995-10-01), Springer et al.
patent: 5473051 (1995-12-01), Altieri et al.
Hay et al in American Type Tissue Culture Collection of Cell Lines and Hybridomas (7 ed) 1992 p. 374 Rockville, Maryland.
Noble et al. J. of Infectious Diseases vol. 162: pp. 909-913 (1990).
Wingard et al. Human Pharmacology: Molecular to Clinical (Kim Kist ed) 1991 pp. 12-16 Mosby Yearbook, St. Louis, Missouri.
Foster David L.
Moyle Matthew
Vlasuk George P.
Basham Daryl A.
Corvas International Inc.
Walsh Stephen
LandOfFree
Neutrophil inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Neutrophil inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Neutrophil inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1175716